Are you Dr. Mehta? This profile is yours to edit: update your address, phone, photo and services.
Edit this profileJayesh Mehta, MD practices hematology in Chicago, IL. Medicare claims data shows Jayesh provided 66,703 services to 2,435 patients. The services billed most often include injection, daratumumab, 10 mg and hyaluronidase-fihj, injection, darbepoetin alfa, 1 microgram (non-esrd use), and injection, teclistamab-cqyv, 0.5 mg. The provider's National Provider Identifier (NPI) is 1790718617.
Factual summary compiled by Guide.md from public records; not written by this provider.
Exactly as CMS reports it (National Downloadable File, Opt-Out Affidavits, Order & Referring). Not an insurance directory; confirm coverage with the office.
675 N SAINT CLAIR ST GALTER 21-100
Chicago, IL 60611
Within Hematology generally. Availability varies by clinician, training and location — this profile has not been claimed, so nothing here is a personal claim by the provider.
Most searched conditions
Anemia
Bleeding disorders
Blood and immune disorders
Blood cancer
Blood clots
Bone marrow disorders
Clotting disorders
Inherited blood disorders
Iron disorders
Lymph conditions
Lymph disorders
Metabolic blood disorders
Nutritional blood disorders
Organ conditions
Platelet disorders
Protein disorders
Red blood cell disorders
White blood cell disorders
Most searched procedures
Biopsy
Blood treatments
Catheter care
Cell therapy
Cellular therapy
Consultation
Consultations
Diagnostic tests
Infusions
Injections
Lab tests
Medication management
Monitoring
Patient education
Procedures
Transfusion therapy
Transplants
Treatments
66,703 services · 2,435 patients · 25 distinct codes
| Procedure | Type | Code | Services | Compared with peers |
|---|---|---|---|---|
| Injection of additional new drug or substance into vein | Treatment | 96375 |
153 | More often than most peers in Hematology |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Treatment | 96401 |
140 | Too few peers to compare |
| Administration of chemotherapy into vein, 1 hour or less | Treatment | 96413 |
119 | More often than most peers in Hematology |
| Injection, daratumumab, 10 mg and hyaluronidase-fihj | Drug given | J9144 |
13,140 | Too few peers to compare |
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Drug given | J0881 |
12,500 | Too few peers to compare |
| Injection, teclistamab-cqyv, 0.5 mg | Drug given | J9380 |
10,404 | Too few peers to compare |
| Injection, oxaliplatin, 0.5 mg | Drug given | J9263 |
6,046 | Too few peers to compare |
| Injection, methylprednisolone sodium succinate, 5 mg | Drug given | J2919 |
4,600 | Too few peers to compare |
| Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | Drug given | J1569 |
3,530 | More than most peers in Hematology |
| Injection, fosaprepitant, 1 mg | Drug given | J1453 |
3,450 | Too few peers to compare |
Source: CMS Medicare public data. Shows how often procedures were billed — not quality of care or patient satisfaction.
Dr. Mehta is a hematology in Chicago, IL. That is the designation recorded for this NPI in the federal registry.
NPI registry
Dr. Mehta is listed at 675 N Saint Clair St Galter 21-100, Chicago, IL 60611. Addresses come from the NPI registry and can lag a move, so confirm before travelling.
NPI registry
The number on file is (312) 695-0990. Contact the office directly to confirm availability and scheduling.
NPI registry
Dr. Mehta's National Provider Identifier is 1790718617. It is issued by the Centers for Medicare & Medicaid Services and is unique and permanent — it does not change if they move practice.
NPI registry
Dr. Mehta attended Other, graduating in 1987. This comes from the CMS National Downloadable File.
CMS public data
Dr. Mehta has 39 years experience. Calculated from a graduation year of 1987, reported in the CMS National Downloadable File.
CMS public data
According to Medicare billing data, Dr. Mehta provides treatments such as injection of additional new drug or substance into vein and administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle, alongside routine visits and testing. This reflects Medicare patients only and is billing volume, not a measure of quality.
Medicare claims
Not yet. This profile is built from public federal data and has not been confirmed by Dr. Mehta. If this is you, claiming it is free.
Guide.md
Guide.md listings do not constitute medical advice or an endorsement.